Abstract:Abstract Background Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and Ulcerative colitis (UC), are chronic and relapsing inflammation occurring among the gastrointestinal tract. Available evidence suggests that host microbiome, as well as various components of the mucosal immune system, are implicated in the pathogenesis of IBD though the exact mechanism remains unknown. Advances in DNA sequencing technologies have provided new insights on the function identification of gut microbiota. In this study, we investigated the gut microbiota response to colitis and discussed the underlying mechanisms of this alteration in combination with latest research. The function of altered microbiota was investigated through microbiota transplantation technology.Results Twenty-seven female C57BL/6J mice were fed DSS solution for 5 days and followed by 5 days normal drinking water. D 0 was considered as normal control while d 5 and d 10 were seen as disease progressive phase and recovery phase, respectively. Alpha diversity results showed that the detected microbiota composition differences among 3 phases were not due to the presence and/or absence of rare phylotypes. In IBD mouse model, community richness decreased but diversity did not change significantly. Besides, the strong negative correlation between phyla Firmicutes and Bacteroidetes decreased in IBD mouse model of which maybe one of the dysbiosis signatures. Furthermore, transplanting microbiota of IBD mouse model to antibiotic-induced microbiota depletion mice (Abx-mice) could induce inflammation similar to colitis. The proportion of the Lactobacillus, as well as other less abundant probiotic taxa, significantly increased in recovery phase, revealing the potential of these probiotic in IBD therapy.Conclusions IBD could induce proportional changes of gut microbiota, and these changes are capable of conferring pathogenicity in Abx-mice. This study provides updated comprehensions of the commensal microbiota alteration.Keywords Gut microbiota, dysbiosis, inflammation bowel disease, DSS, microbiota transplantation

Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model

Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice

Clostridium butyricum and Chitooligosaccharides in Synbiotic Combination Ameliorate Symptoms in a DSS-Induced Ulcerative Colitis Mouse Model by Modulating Gut Microbiota and Enhancing Intestinal Barrier Function

Gut microbiota modulation and anti-inflammatory properties of mixed lactobacilli in dextran sodium sulfate-induced colitis in mice

Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota

Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism

Immunomodulatory Effects of a Probiotic Mixture: Alleviating Colitis in a Mouse Model through Modulation of Cell Activation Markers and the Gut Microbiota

Amelioration of Colitis by a Gut Bacterial Consortium Producing Anti-Inflammatory Secondary Bile Acids

Beneficial and anti-inflammatory effects of formulated prebiotics, probiotics, and synbiotics in normal and acute colitis mice

Microbial Changes Associated with IBD Mouse Model and Microbiota Transplantation Confers Colitis Symptom in Microbiota Deletion Mice

Antioxidant strain Lactiplantibacillus plantarum AS21 and Clostridium butyricum ameliorate DSS-induced colitis in mice by remodeling the assembly of intestinal microbiota and improving gut functions

The Probiotic Effectiveness in Preventing Experimental Colitis is Correlated with Host Gut Microbiota

Core Altered Microorganisms in Colitis Mouse Model: A Comprehensive Time-Point and Fecal Microbiota Transplantation Analysis

Pretreatment with Bifidobacterium longum BAA2573 ameliorates dextran sulfate sodium (DSS)-induced colitis by modulating gut microbiota

Lactobacillus plantarum strains attenuated DSS-induced colitis in mice by modulating the gut microbiota and immune response

Bacteroides acidifaciens and its derived extracellular vesicles improve DSS-induced colitis

Effect of the Combination of Clostridium butyricum and Mycelium of Phellinus igniarius on Intestinal Microbiota and Serum Metabolites in DSS-Induced Colitis

Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseases

A Novel Synbiotic Protects Against DSS-Induced Colitis in Mice via Anti-inflammatory and Microbiota-Balancing Properties

Enhancing Recovery from Gut Microbiome Dysbiosis and Alleviating DSS-Induced Colitis in Mice with a Consortium of Rare Short-Chain Fatty Acid-Producing Bacteria

Lactobacillus fermentum ZS40 Ameliorates Inflammation in Mice With Ulcerative Colitis Induced by Dextran Sulfate Sodium